More countries now have a national plan to fight antimicrobial resistance (AMR), but most have not turned those plans into funded, working programmes, leaving the world off pace for its 2030 targets, the World Health Organization (WHO) said on Monday, November 16.
Source: Reuters
Of 183 countries surveyed, 173 reported having a national action plan to tackle AMR, up from 79 in 2017. Only 42, however, said their plans were financed and implemented, according to the annual survey.
Source: Media Selangor
A survey run by four global agencies
The annual survey is conducted by the WHO together with the United Nations Environment Programme, the World Organization for Animal Health and the Food and Agriculture Organization. At the UN General Assembly in 2024, countries agreed a series of targets for 2030 aimed at tackling AMR, which experts warn could undermine decades of medical advances.
Jean Pierre Nyemazi, acting director of the WHO's AMR department, is the senior official cited in the report. The WHO released the findings as part of its regular tracking of how far national commitments have moved into practice.
Infection prevention is the critical gap
The 2026 survey flagged a critical gap in infection prevention, one of the most effective ways to reduce the need for antibiotics. The WHO said 128 countries now have national infection prevention and control programmes and guidelines, up from 90 countries in 2018. Yet only 69 countries, or 38 per cent, have implemented those programmes nationwide — far short of the target of 90 per cent by 2030.
Laboratory capacity is also uneven. While 131 countries reported having a national reference laboratory capable of testing antibiotic resistance in common bacteria, only 66 countries can test for both bacterial and fungal resistance. The WHO also released two toolkits to help countries strengthen diagnostic capacity, one outlining essential tests and another detailing laboratory procedures.
Surveillance has expanded significantly, the report said, with 113 countries now monitoring antibiotic use and 109 tracking resistance, compared with 65 and 39 countries respectively in 2017. But only 21 countries reported integrating both datasets, a step the WHO says is critical to understanding how antibiotic use drives resistance and to guiding national strategies.
This survey follows the WHO's November 14 warning that drug resistance was associated with more than 4.7 million deaths in 2021 and that AMR pledges must become action. Read the earlier WHO AMR report
What it means for families in Punjab and India
Drug-resistant infections make routine surgery, childbirth care and cancer treatment riskier everywhere, and antibiotics are widely available without prescription across South Asia. The survey's message for governments, including India's, is direct: a plan on paper does not protect patients unless it is financed, staffed and measured. What happens next is whether countries close the funding and infection-prevention gaps before the 2030 deadline.
